Logo Logo Logo Logo Logo

Investor portal

  • About Droia
  • Portfolio
  • People
  • News
  • Careers
  • Contact
  • About Droia
  • Portfolio
  • People
  • News
  • Careers
  • Contact
  • Investor portal

09 Jul Muna Therapeutics Launches with US$ 73M Series A to Advance Novel Small Molecule Therapeutics for Neurodegenerative Diseases

Posted at 16:03h in Muna Therapeutics
Share

announced the successful closing of a US$ 73 million (EUR 60 million) Series A financing round. The investor syndicate was co-led by Novo Holdings, Sofinnova Partners, Droia Ventures and LSP Dementia Fund, with Polaris Partners, Polaris Innovation Fund, Sanofi Ventures, V-Bio Ventures and VIB joining...

Read More
Droia ventures

DROIA SA (LUX)  |  DROIA VENTURES (BE)
contact@droiaventures.com

ESG Disclosures

© DROIA — website made by design